Patent · US Expired

Chemically modified oligonucleotides

US7582744B2 · kind B2 · utility

117Cited by
2References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 2005
Grant dateSep 1, 2009
Priority date
Expiry dateOct 23, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.